🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Salmeterol MDI

Found 53 matching trials

Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate

PHASE1

The purpose of this study is to test the body's response to several doses o...

Status

Completed

Location

Quotient Clinical Ltd

Start Date

2014-07

Trial ID

NCT02232087

Treatments Being Tested

Salmeterol fluticasone propionate

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

PHASE3

The purpose of this study is to determine whether Symbicort dosed according...

Status

Completed

Location

Research Site

Start Date

2004-12

Trial ID

NCT00252863

Treatments Being Tested

Symbicort, used twice daily (b.i.d) and as needed (prn)Budesonide Turbuhaler 200 µg Fluticasone Discus 250 µg Formoterol Turbuhaler 4.5 µg Terbutaline Turbuhaler 0.5 mg Salbutamol pressurized metered dose inhaler (pMDI) 100 µg Salmeterol Discus 50 µg Budesonide/Formoterol Turbuhaler 160/4.5 µg Fluticasone/Salmeterol Discus 250/50 µg Fluticasone/Salmeterol Discus 500/50 µg Theophylline 200 mg Theophylline 300 mg Singulair 10 mg

Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients

The purpose of this study is to investigate the effectiveness of inhaled mo...

Status

Completed

Location

Faculty of Medicine, Ramathibodi Hospital

Start Date

2015-05

Trial ID

NCT02415179

Treatments Being Tested

Inhaled Mometasone/formoterol Inhaled Fluticasone/Salmeterol

Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

This study compared the 14-day bronchodilator efficacy of indacaterol with ...

Status

Completed

Location

Novartis Investigator Site

Start Date

2010-03

Trial ID

NCT01089127

Treatments Being Tested

Indacaterol Salmeterol 50 μg Placebo to indacaterol Placebo to salmeterol

Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg

PHASE2

This is a 16 week multicentre, multinational, randomised, double-blind, dou...

Status

Completed

Location

205.342.43002 Boehringer Ingelheim Investigational Site

Start Date

2006-07

Trial ID

NCT00350207

Treatments Being Tested

Tiotropium bromide Placebo Salmeterol xinafoate

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block

PHASE1

The objective of this pivotal study is to evaluate the relative bioavailabi...

Status

Completed

Location

Clinical Pharmacology Unit of Mackay Memorial Hospital Tamshui Branch

Start Date

2014-08

Trial ID

NCT02466503

Treatments Being Tested

Fluticasone propionate Salmeterol (as xinafoate)

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)

PHASE4

The objectives of this study are to measure Impulse Oscillometry (IOS) in p...

Status

Unknown

Location

Allergy and Asthma Center of El Paso

Start Date

2008-09

Trial ID

NCT00867737

Treatments Being Tested

Advair HFA MDI 115/21 Symbicort 160/4.5 pMDI

Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

PHASE4

The purpose of this study is to evaluate the site and mechanisms responsibl...

Status

Recruiting

Location

Arthur F Gelb Medical Corporation

Start Date

2007-10

Trial ID

NCT01225913

Treatments Being Tested

fluticasone/salmeterol in all asthmatics budesonide/formoterol or fluticasone/salmeterol in all asthmatics

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

PHASE3

A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-10-13

Trial ID

NCT02924688

Treatments Being Tested

FF/UMEC/VI (100/31.25/25) mcg FF/UMEC/VI (100/62.5/25) mcg FF/UMEC/VI (200/31.25/25) mcg FF/UMEC/VI (200/62.5/25) mcg FF/VI (100/25) mcg FF/VI (200/25) mcg Fluticasone/salmeterol (FSC)Albuterol/salbutamol ELLIPTA DPI DISKUS DPI METERED-DOSE INHALER (MDI)

The Effect of Salmeterol on Eosinophil (EOS) Function

This study is designed to test the hypothesis that salmeterol use, and not ...

Status

Completed

Location

University of Wisconsin

Start Date

2003-11

Trial ID

NCT00214019

Treatments Being Tested

salmeterol Fluticasone Placebo

Previous Next